Skip to main content
OpenTrials

Clinical trial condition

Neuromuscular Junction Diseases

Explore clinical trials studying Neuromuscular Junction Diseases. Study availability and eligibility vary by location and protocol.

296 public trials 100 recruiting studies
Refine in advanced search Browse all conditions

Neuromuscular Junction Diseases trial results

Recruiting

Zilucoplan for Severe gMG Exacerbations

NCT07215949

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Generalized Myasthenia Gravis (gMG), +11 more
Locations
  • The Ohio State University Columbus, Ohio, United States
  • University of South Florida/Tampa General Hospital Tampa, Florida, United States
  • University of Kansas Medical Center Kansas City, Kansas, United States
View Trial Details
Recruiting

Safety and Efficacy of 3 Dose Levels of NMD670 in Adult Patients With Myasthenia Gravis

NCT06414954

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Immune System Diseases, +11 more
Locations
  • Profound Research LLC Carlsbad, California, United States
  • University of California Irvine Medical Center Irvine, California, United States
  • University of Colorado Neuromuscular Division Aurora, Colorado, United States
  • SFM Clinical Research, LLC Boca Raton, Florida, United States
View all 40 locations
View Trial Details
Recruiting

A Clinical Study of B007 in the Treatment of Generalized Myasthenia Gravis.

NCT06447597

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Generalized Myasthenia Gravis, +11 more
Locations
  • Peking University First Hospital Beijing, China
  • The First Bethune Hospital of Jilin University Changchun, China
  • Xiangya Hospital Central South University Changsha, China
  • Sichuan Provincial People's Hospital Chengdu, China
View all 18 locations
View Trial Details
Recruiting

A Study Evaluating the Safety and Efficacy of KITE-363 in Relapsed/Refractory Autoimmune Neurologic Diseases

NCT07304154

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Chronic Disease, +22 more
Locations
  • Stanford Neuroscience Health Center Palo Alto, California, United States
  • Columbia University Irving Medical Center New York, United States
  • LDS Hospital - Intermountain Health Salt Lake City, Utah, United States
  • Fred Hutchinson Cancer Center Seattle, Washington, United States
View Trial Details
Recruiting

RESET-MG: A Study to Evaluate the Safety and Efficacy of CABA-201 in Participants With Generalized Myasthenia Gravis

NCT06359041

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Generalized Myasthenia Gravis (gMG), +11 more
Locations
  • University of California Irvine Orange, California, United States
  • UC Davis, Department of Neurology Sacramento, California, United States
  • University of California, San Francisco San Francisco, California, United States
  • University of Colorado Aurora, Colorado, United States
View all 17 locations
View Trial Details

Related conditions